These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 404419)
1. The effects of probenecid upon the individual components of indomethacin elimination. Duggan DE; Hooke KF; White SD; Noll RM; Stevenson CR J Pharmacol Exp Ther; 1977 May; 201(2):463-70. PubMed ID: 404419 [TBL] [Abstract][Full Text] [Related]
2. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. Ueda K; Kato Y; Komatsu K; Sugiyama Y J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability of indomethacin in man. Baer JE; Hucker HB; Duggan DE Ann Clin Res; 1974; 6(0):suppl 11:44-7. PubMed ID: 4211834 [No Abstract] [Full Text] [Related]
6. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074 [TBL] [Abstract][Full Text] [Related]
7. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Duggan DE; Hooke KF; Noll RM; Kwan KC Biochem Pharmacol; 1975 Oct; 24(19):1749-54. PubMed ID: 823946 [No Abstract] [Full Text] [Related]
8. Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey. Shou M; Lu W; Kari PH; Xiang C; Liang Y; Lu P; Cui D; Emary WB; Michel KB; Adelsberger JK; Brunner JE; Rodrigues AD Eur J Pharm Sci; 2005 Oct; 26(2):151-61. PubMed ID: 16085400 [TBL] [Abstract][Full Text] [Related]
9. Metabolic clearance of furosemide in the rat. Wallin JD; Ryals P; Kaplowitz N J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections. Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818 [TBL] [Abstract][Full Text] [Related]
11. Enterohepatic circulation of methotrexate in rats in vivo. Steinberg SE; Campbell CL; Bleyer WA; Hillman RS Cancer Res; 1982 Apr; 42(4):1279-82. PubMed ID: 7060005 [TBL] [Abstract][Full Text] [Related]
12. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876 [TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat. Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177 [TBL] [Abstract][Full Text] [Related]
14. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947 [TBL] [Abstract][Full Text] [Related]
15. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling. Feng MR; Loo J; Wright J Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403 [TBL] [Abstract][Full Text] [Related]
16. Probenecid-induced effects on bile flow and biliary excretion of 3H-ouabain. Erttmann RR; Damm KH Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):96-106. PubMed ID: 999406 [TBL] [Abstract][Full Text] [Related]
17. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man. Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233 [TBL] [Abstract][Full Text] [Related]
18. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals. Schillings RT; Sisenwine SF Drug Metab Dispos; 1986; 14(4):405-12. PubMed ID: 2873986 [TBL] [Abstract][Full Text] [Related]
19. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat. Savina PM; Brouwer KL Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724 [TBL] [Abstract][Full Text] [Related]
20. Effects of sodium salicylate on elimination kinetics of indomethacin and bile production in dogs. Beck WS; Dietzel K; Geisslinger G; Engler H; Vergin H; Brune K Drug Metab Dispos; 1990; 18(6):962-7. PubMed ID: 1981545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]